Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bargman

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Clinical Nephrology|July 19, 2011
Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal diseaseM Battistella, R M A Richardson, J M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 29, 2014
Peritonitis caused by veillonella species and Eggerthella lenta in peritoneal dialysisR Goupil, A C Nadeau-Fredette, K K Tennankore, et al.
American Journal of Nephrology|January 1, 1990
Fibrillary glomerulonephritis in a patient with metastatic carcinoma of the liverG Abraham, J M Bargman, P G Blake, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 16, 1999
Calciphylaxis precipitated by ultraviolet light in a patient with end-stage renal disease secondary to systemic lupus erythematosusL R James, G Lajoie, D Prajapati, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 14, 2008
Pericatheter leak with air bubbles in the effluent of a patient on chronic peritoneal dialysis without peritonitis: your diagnosis?S N Tapiawala, T C Penner, J M Bargman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 2001
Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal functionM K Menon, D M Naimark, J M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 15, 1998
Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit siteE Thodis, S Bhaskaran, P Pasadakis, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 5, 1999
Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysisE Thodis, S I Vas, J M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2002
Is catheter function influenced by the side of the body in which the peritoneal dialysis catheter is placed?M C de la Cruz, N Dimkovic, J M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 28, 2000
Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting itM K Singhal, S Bhaskaran, E Vidgen, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Clinical Nephrology|July 19, 2011
Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal diseaseM Battistella, R M A Richardson, J M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 29, 2014
Peritonitis caused by veillonella species and Eggerthella lenta in peritoneal dialysisR Goupil, A C Nadeau-Fredette, K K Tennankore, et al.
American Journal of Nephrology|January 1, 1990
Fibrillary glomerulonephritis in a patient with metastatic carcinoma of the liverG Abraham, J M Bargman, P G Blake, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 16, 1999
Calciphylaxis precipitated by ultraviolet light in a patient with end-stage renal disease secondary to systemic lupus erythematosusL R James, G Lajoie, D Prajapati, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 14, 2008
Pericatheter leak with air bubbles in the effluent of a patient on chronic peritoneal dialysis without peritonitis: your diagnosis?S N Tapiawala, T C Penner, J M Bargman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 2001
Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal functionM K Menon, D M Naimark, J M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 15, 1998
Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit siteE Thodis, S Bhaskaran, P Pasadakis, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 5, 1999
Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysisE Thodis, S I Vas, J M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2002
Is catheter function influenced by the side of the body in which the peritoneal dialysis catheter is placed?M C de la Cruz, N Dimkovic, J M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 28, 2000
Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting itM K Singhal, S Bhaskaran, E Vidgen, et al.
Pageof 7